卵巢癌起病隐匿、进展快,缺乏有效的早期诊断手段,约７０%的患者一经发现即已为晚期。虽然近年来手术、化疗和放疗获得重大进展,但晚期卵巢癌的五年生存率仍长期徘徊在２０%～３０%［１］,人们在努力寻找一种新的更有效的治疗方法来改善其预后。其中细胞因子治疗是研究的热点, Occult onset of occult ovarian cancer, rapid progress, the lack of effective early diagnosis, about 70% of patients found to have advanced. Although significant progress has been made in surgery, chemotherapy and radiotherapy in recent years, the five-year survival rate of advanced ovarian cancer remains hovering at 20% to 30% for a long time [1]. People are trying to find a new and more effective treatment to improve their Prognosis. Among them, cytokine therapy is the hot spot of research,